Identifying surrogate markers in real-world comparative effectiveness research

DOI10.1002/SIM.9569zbMATH Open1547.62255MaRDI QIDQ6629372FDOQ6629372

Authors: Xuan Wang, Tianxi Cai 

Publication date: 29 October 2024

Published in: Statistics in Medicine (Search for Journal in Brave)

zbMATH Keywords

double robustnesssemi-nonparametric estimationsurrogate markercomparative effectiveness researchproportion of treatment effect explainedinflammatory bowel disease

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Cites Work

• A simple resampling method by perturbing the minimand
• On the Cox Model With Time-Varying Regression Coefficients
• Title not available (Why is that?)
• Causal Inference for Statistics, Social, and Biomedical Sciences
• Estimation of Regression Coefficients When Some Regressors Are Not Always Observed
• Title not available (Why is that?)
• Title not available (Why is that?)
• Surrogate measures and consistent surrogates
• A Measure of the Proportion of Treatment Effect Explained by a Surrogate Marker
• Irregular identification, support conditions, and inverse weight estimation
• Causal Inference Using Potential Outcomes
• Non-parametric analysis of a generalized regression model. The maximum rank correlation estimator
• The Limiting Distribution of the Maximum Rank Correlation Estimator
• Overlap in observational studies with high-dimensional covariates
• Inference on finite-population treatment effects under limited overlap
• Model-free approach to quantifying the proportion of treatment effect explained by a surrogate marker
• Robust Approach to Combining Multiple Markers to Improve Surrogacy

Cited In (1)

• Flexible evaluation of surrogate markers with Bayesian model averaging

This page was built for publication: Identifying surrogate markers in real-world comparative effectiveness research

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6629372)